You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,178 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-21
Sep 21, 2021
C
Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • (no location specified)
2021-09-13
Sep 13, 2021
H
Recruiting
  • Glioblastoma
  • Bortezomib and Temozolomide Phase IB
  • Bortezomib and Temozolomide Phase II
  • Bergen, Norway
  • +1 more
2021-08-24
Aug 24, 2021
U
Completed
  • Multiple Myeloma
  • Vorinostat Velcade Dexamethasone
  • Nottingham, Nottinghamshire, United Kingdom
  • +1 more
2021-08-09
Aug 9, 2021
E
Active, not recruiting
  • Multiple Myeloma
  • Rionero in Vulture, Potenza, Italy
    Irccs Crob
2021-02-04
Feb 4, 2021
P
Recruiting
  • Autoimmune Hemolytic Anemia
  • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
  • combination of a single dose anti-CD20 antibody and bortezomib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
2021-10-12
Oct 12, 2021
N
Completed
  • Lung Diseases, Interstitial
  • +2 more
  • Bortezomib
  • +2 more
  • Chicago, Illinois
    Northwestern University
2021-08-02
Aug 2, 2021
U
Active, not recruiting
  • Waldenström's Macroglobulinemia
  • Dexamethasone, Rituximab, Cyclophosphamide
  • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
  • Ulm, Germany
    University Hospital Ulm
2021-05-03
May 3, 2021
S
Recruiting
  • Antibody-mediated Rejection
  • Bortezomib
  • Tehran, Iran, Islamic Republic of
    SBMU
2020-12-30
Dec 30, 2020
N
Recruiting
  • Neoplasms
  • +2 more
  • Bortezomib plus Clofarabine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-02
Sep 2, 2021
P
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Ibrutinib and Bortezomib + R-CHOP
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
2021-01-25
Jan 25, 2021
P
Recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bortezomib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-10-06
Oct 6, 2021
H
Recruiting
  • Hematological Malignancy
  • Bortezomib
  • Detroit, Michigan
    Henry Ford hospital
2020-11-03
Nov 3, 2020
E
Completed
  • Multiple Myeloma
  • Bortezomib
  • +3 more
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
2021-11-01
Nov 1, 2021
D
Terminated
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-04-22
Apr 22, 2021
R
Terminated
  • Follicular Lymphoma
  • Bortezomib and Tositumomab I-131
  • Chicago, Illinois
    Rush University Medical Center
2021-10-06
Oct 6, 2021
J
Completed
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
2021-02-04
Feb 4, 2021
A
Completed
  • Chronic Antibody-mediated Transplant Rejection
  • Bortezomib
  • Plasma exchanges and intravenous immunoglobulins
  • Paris, France
    Hopital Necker Enfants-malades
2020-09-14
Sep 14, 2020
M
Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
2021-02-23
Feb 23, 2021
U
Recruiting
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
2021-02-10
Feb 10, 2021